Provided by Tiger Trade Technology Pte. Ltd.

BRII-B

1.420
-0.020-1.39%
Volume:1.77M
Turnover:2.48M
Market Cap:1.02B
PE:-1.83
High:1.440
Open:1.440
Low:1.390
Close:1.440
52wk High:3.090
52wk Low:0.960
Shares:721.00M
HK Float Shares:721.00M
Volume Ratio:1.14
T/O Rate:0.25%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.775
ROE:-14.42%
ROA:-8.42%
PB:0.37
PE(LYR):-1.83
PS:31.96

Loading ...

BRIEF-Brii Biosciences And OpenBench Announce AI-Driven Collaboration For Proprietary Technology Platform

Reuters
·
Dec 11

Brii Biosciences and Openbench Announce AI-Driven Collaboration for Proprietary Technology Platform

THOMSON REUTERS
·
Dec 11

Openbench - Collaboration May Expand to Include Additional Programs

THOMSON REUTERS
·
Dec 11

Openbench - to Receive Payment for Delivering Novel Leads That Meet Specific Criteria Defined by Brii Bio

THOMSON REUTERS
·
Dec 11

Openbench - Brii Bio to Gain Exclusive Rights to Leads and Co's Technology

THOMSON REUTERS
·
Dec 11

HK Movers | Biotech Stocks Rise. Ascletis up 9%; Antengene up over 5%; Remegen, Laekna, Akeso, Hua Medicine up About 4%

Tiger Newspress
·
Dec 04

Brii Biosciences (02137) Releases Monthly Return for November 2025

Bulletin Express
·
Dec 03

HK Movers | Biotech Stocks Fall. Ascletis-B down 11%; Hua Medicine-B, Mabpharm-B down about 7%; Antengene-B down 5%; Ascentage-B down 4%.

Tiger Newspress
·
Dec 03

HK Pharma Shares Gained. CSPC Pharma Up 7%; 3SBio Up 6%; Remegen Up 4%; Sino Biopharm, Junshi Bio And Hengrui Pharma Up 3%

Tiger Newspress
·
Nov 26

HK Movers|Biotech Shares Gained. 3SBio And Hengrui Pharma Up 5%; Tigermed Up 3%; SKB Bio, JW Therap, Remegen And Wuxi XDC Up 2%

Tiger Newspress
·
Nov 24

Hong Kong Stocks Movement | Biotech Concept Stocks Lead Declines as BD Deals Cool and Rate Cut Expectations Fade

Stock News
·
Nov 21

Brii Biosciences Limited (Stock Code: 2137) Announces Revised Nomination Committee Terms

Bulletin Express
·
Nov 16

Brii Biosciences (2137) Presents Phase 2 ENSURE Study Results at AASLD 2025

Bulletin Express
·
Nov 10

BRII-B (02137) Presents Breakthrough Phase II ENSURE Study Data at 2025 AASLD Conference

Stock News
·
Nov 10

Brii Biosciences Reports Positive Phase 2 ENSURE Study Results for Hepatitis B Therapy

Reuters
·
Nov 10

Brii Biosciences (Stock Code: 2137) Publishes Phase 2 ENSURE Study Results in Nature Medicine

Bulletin Express
·
Nov 07

BRII-B (02137): ENSURE Phase II Study Results Published in Nature Medicine

Stock News
·
Nov 07

Brii Biosciences Reports Phase 2 ENSURE Study Results on HBV Cure Strategy in Nature Medicine

Reuters
·
Nov 07

Brii Biosciences (02137) Announces 613,412-Share Increase in October 2025

Bulletin Express
·
Nov 05

BRII-B Grants 600,000 Share Options

Deep News
·
Nov 02